STAT+: FDA’s new ‘plausible mechanism pathway’ for personalized gene editing raises concerns

The FDA has introduced a new pathway called the "plausible mechanism pathway" aimed at facilitating one-time gene-editing cures. However, ethicists have raised concerns that this approach could lead to significant ethical dilemmas, potentially becoming a "Pandora's box."